• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
International Differences in Multiple Sclerosis Health Outcomes and Associated Factors in a Cross-sectional Survey.一项横断面调查中多发性硬化症健康结局及相关因素的国际差异
Front Neurol. 2017 May 31;8:229. doi: 10.3389/fneur.2017.00229. eCollection 2017.
2
Pain in People with Multiple Sclerosis: Associations with Modifiable Lifestyle Factors, Fatigue, Depression, Anxiety, and Mental Health Quality of Life.多发性硬化症患者的疼痛:与可改变的生活方式因素、疲劳、抑郁、焦虑及心理健康生活质量的关联
Front Neurol. 2017 Sep 5;8:461. doi: 10.3389/fneur.2017.00461. eCollection 2017.
3
Latitude, sun exposure and vitamin D supplementation: associations with quality of life and disease outcomes in a large international cohort of people with multiple sclerosis.纬度、阳光照射与维生素D补充:在一个大型国际多发性硬化症患者队列中与生活质量和疾病结局的关联
BMC Neurol. 2015 Aug 5;15:132. doi: 10.1186/s12883-015-0394-1.
4
Lifestyle, medication and socio-demographic determinants of mental and physical health-related quality of life in people with multiple sclerosis.多发性硬化症患者心理健康相关生活质量和身体健康相关生活质量的生活方式、药物治疗及社会人口学决定因素
BMC Neurol. 2016 Nov 22;16(1):235. doi: 10.1186/s12883-016-0763-4.
5
Differential multiple sclerosis treatment allocation between Australia and New Zealand associated with clinical outcomes but not mood or quality of life.澳大利亚和新西兰之间多发性硬化症的治疗分配差异与临床结果相关,但与情绪或生活质量无关。
Mult Scler Relat Disord. 2019 May;30:25-32. doi: 10.1016/j.msard.2019.01.037. Epub 2019 Jan 24.
6
Quality of life in patients with multiple sclerosis: the impact of depression, fatigue, and disability.多发性硬化症患者的生活质量:抑郁、疲劳和残疾的影响。
Int J Rehabil Res. 2011 Dec;34(4):290-8. doi: 10.1097/MRR.0b013e32834ad479.
7
Quality of life in patients with multiple sclerosis: the impact of fatigue and depression.多发性硬化症患者的生活质量:疲劳和抑郁的影响。
J Neurol Sci. 2002 Dec 15;205(1):51-8. doi: 10.1016/s0022-510x(02)00312-x.
8
Depression, fatigue and disability are independently associated with quality of life in patients with multiple Sclerosis: Results of a cross-sectional study.抑郁、疲劳和残疾与多发性硬化症患者的生活质量独立相关:一项横断面研究的结果。
Mult Scler Relat Disord. 2019 Oct;35:262-269. doi: 10.1016/j.msard.2019.07.029. Epub 2019 Jul 28.
9
Associations of Lifestyle, Medication, and Socio-Demographic Factors with Disability in People with Multiple Sclerosis: An International Cross-Sectional Study.生活方式、药物治疗及社会人口学因素与多发性硬化症患者残疾的相关性:一项国际横断面研究
PLoS One. 2016 Aug 25;11(8):e0161701. doi: 10.1371/journal.pone.0161701. eCollection 2016.
10
Fatigue, depression, and health-related quality of life in patients with multiple sclerosis in Isfahan, Iran.伊朗伊斯法罕多发性硬化症患者的疲劳、抑郁和健康相关生活质量。
Eur J Neurol. 2012 Mar;19(3):431-7. doi: 10.1111/j.1468-1331.2011.03535.x. Epub 2011 Oct 4.

引用本文的文献

1
The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries: a propensity-score-matched cohort study.12个国家中COVID-19感染对多发性硬化病程的影响:一项倾向评分匹配队列研究。
Ther Adv Neurol Disord. 2024 Nov 7;17:17562864241278496. doi: 10.1177/17562864241278496. eCollection 2024.
2
Assessment of the Multiple Sclerosis Severity Score and the Age-Related Multiple Sclerosis Severity Score as health indicators in a population-based cohort.评估多发性硬化严重程度评分和年龄相关多发性硬化严重程度评分作为基于人群队列中的健康指标。
Neurol Sci. 2025 Jan;46(1):335-342. doi: 10.1007/s10072-024-07767-3. Epub 2024 Sep 17.
3
Treatment of older patients with multiple sclerosis: Results of an International Delphi Survey.老年多发性硬化症患者的治疗:一项国际德尔菲调查的结果。
Mult Scler J Exp Transl Clin. 2023 Sep 13;9(3):20552173231198588. doi: 10.1177/20552173231198588. eCollection 2023 Jul-Sep.
4
A Systematic Review and Meta-Analysis of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS) International Validations.多发性硬化症简短认知评估(BICAMS)国际验证的系统评价与荟萃分析
J Clin Med. 2023 Jan 16;12(2):703. doi: 10.3390/jcm12020703.
5
Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review.多发性硬化相关疲劳的患病率及负担:一项系统文献综述
BMC Neurol. 2021 Dec 2;21(1):468. doi: 10.1186/s12883-021-02396-1.
6
Predicting onset of secondary-progressive multiple sclerosis using genetic and non-genetic factors.利用遗传和非遗传因素预测继发进展性多发性硬化症的发病。
J Neurol. 2020 Aug;267(8):2328-2339. doi: 10.1007/s00415-020-09850-z. Epub 2020 Apr 24.

本文引用的文献

1
Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop.多发性硬化症的环境可改变风险因素:2016年ECTRIMS聚焦研讨会报告
Mult Scler. 2018 Apr 1;24(5):590-603. doi: 10.1177/1352458516686847.
2
Lifestyle, medication and socio-demographic determinants of mental and physical health-related quality of life in people with multiple sclerosis.多发性硬化症患者心理健康相关生活质量和身体健康相关生活质量的生活方式、药物治疗及社会人口学决定因素
BMC Neurol. 2016 Nov 22;16(1):235. doi: 10.1186/s12883-016-0763-4.
3
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.高纬度与多发性硬化症的发病年龄较早显著相关。
J Neurol Neurosurg Psychiatry. 2016 Dec;87(12):1343-1349. doi: 10.1136/jnnp-2016-314013. Epub 2016 Nov 3.
4
Associations of Lifestyle, Medication, and Socio-Demographic Factors with Disability in People with Multiple Sclerosis: An International Cross-Sectional Study.生活方式、药物治疗及社会人口学因素与多发性硬化症患者残疾的相关性:一项国际横断面研究
PLoS One. 2016 Aug 25;11(8):e0161701. doi: 10.1371/journal.pone.0161701. eCollection 2016.
5
Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors.国际多发性硬化症患者样本中共病、超重和肥胖的患病率及其与可改变生活方式因素的关联
PLoS One. 2016 Feb 5;11(2):e0148573. doi: 10.1371/journal.pone.0148573. eCollection 2016.
6
A telemedicine meditation intervention for people with multiple sclerosis and their caregivers: study protocol for a randomized controlled trial.一项针对多发性硬化症患者及其护理人员的远程医疗冥想干预:一项随机对照试验的研究方案。
Trials. 2016 Jan 4;17:4. doi: 10.1186/s13063-015-1136-9.
7
Safety and efficacy of fingolimod in clinical practice: The experience of an academic center in the Middle East.芬戈莫德在临床实践中的安全性和有效性:中东某学术中心的经验。
J Neuroimmunol. 2015 Dec 15;289:93-7. doi: 10.1016/j.jneuroim.2015.10.015. Epub 2015 Oct 26.
8
Latitude, sun exposure and vitamin D supplementation: associations with quality of life and disease outcomes in a large international cohort of people with multiple sclerosis.纬度、阳光照射与维生素D补充:在一个大型国际多发性硬化症患者队列中与生活质量和疾病结局的关联
BMC Neurol. 2015 Aug 5;15:132. doi: 10.1186/s12883-015-0394-1.
9
Clinically significant fatigue: prevalence and associated factors in an international sample of adults with multiple sclerosis recruited via the internet.具有临床意义的疲劳:通过互联网招募的国际多发性硬化症成年患者样本中的患病率及相关因素
PLoS One. 2015 Feb 18;10(2):e0115541. doi: 10.1371/journal.pone.0115541. eCollection 2015.
10
The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review.多发性硬化症中心境障碍的发病率和患病率:系统评价。
Mult Scler. 2015 Mar;21(3):305-17. doi: 10.1177/1352458514564487. Epub 2015 Jan 12.

一项横断面调查中多发性硬化症健康结局及相关因素的国际差异

International Differences in Multiple Sclerosis Health Outcomes and Associated Factors in a Cross-sectional Survey.

作者信息

Reilly Grace D, Mahkawnghta Awng Shar, Jelinek Pia L, De Livera Alysha M, Weiland Tracey J, Brown Chelsea R, Taylor Keryn L, Neate Sandra L, Jelinek George A, Marck Claudia H

机构信息

Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.

Sir Charles Gairdner Hospital, Nedlands, WA, Australia.

出版信息

Front Neurol. 2017 May 31;8:229. doi: 10.3389/fneur.2017.00229. eCollection 2017.

DOI:10.3389/fneur.2017.00229
PMID:28620343
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5450014/
Abstract

Multiple sclerosis (MS) is a major cause of disability and poor quality of life (QOL). Previous studies have shown differences in MS health outcomes between countries. This study aimed to examine the associations between international regions and health outcomes in people with MS. Self-reported data were taken from the Health Outcomes and Lifestyle In a Sample of people with Multiple Sclerosis online survey collected in 2012. The 2,401 participants from 37 countries were categorized into three regions: Australasia, Europe, and North America. Differences were observed between regions in disability, physical and mental health QOL, fatigue, and depression, but most of these disappeared after adjusting for sociodemographic, disease, and lifestyle factors in multivariable regression models. However, adjusted odds for disability were higher in Europe [odds ratio (OR): 2.17, 95% confidence interval (CI): 1.28 to 3.67] and North America (OR: 1.79, 95% CI: 1.28 to 2.51) compared to Australasia. There may be other unmeasured factors that vary between regions, including differences in access and quality of healthcare services, determining disability in MS. When assessing differences in MS health outcomes, lifestyle factors and medication use should be taken into consideration.

摘要

多发性硬化症(MS)是导致残疾和生活质量(QOL)低下的主要原因。先前的研究表明,不同国家的MS健康结局存在差异。本研究旨在探讨国际区域与MS患者健康结局之间的关联。自我报告数据取自2012年收集的多发性硬化症患者样本中的健康结局与生活方式在线调查。来自37个国家的2401名参与者被分为三个区域:澳大拉西亚、欧洲和北美。在残疾、身心健康QOL、疲劳和抑郁方面观察到区域间存在差异,但在多变量回归模型中对社会人口统计学、疾病和生活方式因素进行调整后,这些差异大多消失。然而,与澳大拉西亚相比,欧洲(优势比[OR]:2.17,95%置信区间[CI]:1.28至3.67)和北美的残疾调整优势更高(OR:1.79,95%CI:1.28至2.51)。可能存在其他区域间不同的未测量因素,包括医疗服务的可及性和质量差异,这些因素决定了MS患者的残疾情况。在评估MS健康结局的差异时,应考虑生活方式因素和药物使用情况。